Phase IIb study of Icosabutate in patients with Non-alcoholic-steatohepatitis.
Phase of Trial: Phase II
Latest Information Update: 19 Dec 2017
At a glance
- Drugs Icosabutate (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- 19 Dec 2017 New trial record
- 12 Dec 2017 According to a Northsea therapeutics media release, company expects to initiate this trial by the end of 2018.